2023-12-23 07:18:16 ET
Here is The Deal With Marijuana Stocks And Federal Reform
Cannabis reform has been an ongoing battle for many years now. Yet it has been a difficult process to get the job done. Currently, there is still an ongoing push to pass marijuana banking reform and the rescheduling of cannabis. However, neither bills make it past the Senate as this is where the wall has been for federal reform. Now with the progress and development of the legal market, it’s doubtful there will be any type of federal interference. Yet the big question is when will politicians see the upside to federally legalizing cannabis.
If you are an investor then you know that positive news on the matter has helped marijuana stocks trade better. In fact, this has been the main reason that cannabis stocks have been able to see recoveries in the market. Nonetheless, it’s only a matter of time before we see the eventual passing of federal reform. Now it would be ideal to have cannabis reclassified so it opens the industry as a whole. But it seems like cannabis banking reform is what many are gearing towards.
This is becuase cannabis is still federally illegal so banks can not work with legal businesses. However, in the near future, this can all change in favor of the cannabis industry. Not to mention it will strengthen the market and make the possibility to see healthier trading for marijuana stocks. Also when federal reform finally passes we may see more people look for marijuana stocks to buy once the legal framework in in place.
Marijuana Stocks To Watch In 2024
- Trulieve Cannabis Corp. ( OTC:TCNNF )
- Curaleaf Holdings, Inc. ( OTC:CURLF )
- Jushi Holdings Inc. ( OTC:JUSHF )
Trulieve Cannabis Corp.
Trulieve Cannabis Corp. together with its subsidiaries, operates as a medical cannabis company. The company cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, as well as through home delivery.
In recent news, the company announced the appointment of Wes Getman as Chief Financial Officer, effective January 1, 2024. Mr. Getman has over 25 years of experience in accounting and finance in both corporate and advisory roles for private and public companies including Blue Bird Corporation, Grant Thornton, and PricewaterhouseCoopers.
Curaleaf Holdings, Inc.
Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through Domestic Operations and International Operations segments. The company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels.
Recently the company announced it has complied with all the conditions listed in the conditional listing approval. Which is delivered by the Toronto Stock Exchange (the “TSX”) in connection with the listing of its subordinate voting shares (the “Shares”) on the TSX.
Words From The Company
“Curaleaf’s official listing on the Toronto Stock Exchange marks an incredible day not just for our company, but the entire global cannabis industry,” said Executive Chairman Boris Jordan.”
[Read More] 2024’s Cannabis Investment Landscape: Top Marijuana ETFs to Consider
Jushi Holdings Inc.
Jushi Holdings Inc. a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of medical and adult-use products. It focuses on building a portfolio of cannabis assets in various jurisdictions in Pennsylvania, Virginia, Ohio, Illinois, California, Nevada, and Massachusetts. On November 23rd the company announced the filing of a preliminary base shelf prospectus.
The Shelf Prospectus, when made final and effective, will allow the Company to offer up to C$600 million of subordinate voting shares, preferred shares. In addition to subscription receipts, debt securities, convertible securities, warrants, and units or any combination thereof, from time to time during the 25 months that the Shelf Prospectus is effective.
[Read More] Marijuana Stocks To Watch That Are Impacted By Cannabis Reform
The Company intends to file the Final Shelf Prospectus to maintain financial flexibility, including responding to significant regulatory improvements and pursuing opportunistic acquisitions.
